Written by Holly Alyssa MacCormick Ask Vito Imbasciani about his career and you will not hear a simple answer—you will hear a story of service to his country and to the people of California. Imbasciani, PhD, MD, FACS, Colonel (ret.), has chaired the board of the California Institute for Regenerative Medicine (CIRM) since March 28, … Continue reading A life of service: A conversation with CIRM Board Chair Vito Imbasciani
Features
A conversation with CIRM board member Yael Wyte
Written by Holly Alyssa MacCormick Yael Wyte knows all too well how difficult it can be to have or care for someone with Alzheimer’s Disease—she has been working with and advocating for people with Alzheimer's Disease for more than 20 years. Earlier this year, Wyte joined the board of the California Institute for Regenerative Medicine … Continue reading A conversation with CIRM board member Yael Wyte
“An awesome responsibility”: A conversation with CIRM board member Kim Barrett
Written by Holly Alyssa MacCormick It’s not every day that you get to contribute to something that could help save a life, but when Kim Barrett joined the board of the California Institute for Regenerative Medicine (CIRM), that’s exactly what happened. Decades of research experience Barrett is a research physiologist. For 36 years, she studied … Continue reading “An awesome responsibility”: A conversation with CIRM board member Kim Barrett
CIRM COMPASS scholar road to becoming a physician
Written by Holly Alyssa MacCormick Image Credit: Maya Singh Many paths can lead to a career as a physician. For undergraduate Maya Singh, the road to becoming a doctor begins at a laboratory bench in the University of California, Berkeley. “I believe that being a part of research is a huge step toward being a … Continue reading CIRM COMPASS scholar road to becoming a physician
Gene Therapy for Heart Failure: A Conversation with Eric Adler, MD
Image Credit: The Adler Lab at the University of California, San Diego In the fall of 2024, the California Institute for Regenerative Medicine (CIRM) helped sponsor the Gene Therapy Initiative symposium in La Jolla, CA. While there, CIRM staff caught up with a few CIRM grantees who are working on gene therapy approaches to treating … Continue reading Gene Therapy for Heart Failure: A Conversation with Eric Adler, MD
Gene therapies for Friedreich’s Ataxia: A conversation with Liz Soragni, PhD
Liz Soragni, PhD, Director of Research at the Friedreich’s Ataxia Research Alliance In the fall of 2024, the California Institute for Regenerative Medicine (CIRM) helped sponsor the Gene Therapy Initiative symposium in La Jolla, CA. While there, CIRM staff caught up with a few CIRM grantees who are working on gene therapy approaches to treating … Continue reading Gene therapies for Friedreich’s Ataxia: A conversation with Liz Soragni, PhD
The Stem Cellar’s Most Read Blogs of 2024
2024 was a significant year for the California Institute for Regenerative Medicine (CIRM). We reached many milestones, including celebrating our 20th anniversary and introducing our Strategic Allocation Framework (SAF) impact goals, all while continuing to fund innovative research and advancements in regenerative medicine.The Stem Cellar blog is where we share these stories and achievements, providing … Continue reading The Stem Cellar’s Most Read Blogs of 2024
Potential Gene Therapy for Children with ADA-SCID
Photo Courtesy of Andrea Fernandez de Soto Imagine stepping outside and facing life‑threatening danger. For children born with ADA‑SCID (adenosine deaminase severe combined immunodeficiency), this is daily life. Their immune systems are so weak that a cold or a scraped knee can cause a dangerous infection. Donald Kohn, MD, a leading researcher at the UCLA … Continue reading Potential Gene Therapy for Children with ADA-SCID
Story of Hope: Elpida Therapeutics’ Pioneer Study on Rare Nerve Disease CMT4J
CIRM awarded Elpida Therapeutics a $3.9 million grant in December 2023 to support a pioneering preclinical study on Charcot Marie Tooth disease type 4J (CMT4J).
A Conversation with CEO Cory Nicholas on Neurona Therapeutics’ Recent RMAT Designation
At the California Institute for Regenerative Medicine (CIRM), we enjoy highlighting achievements that come out of the research we support. We recently sat down with Cory Nicholas, PhD, CEO and Co-Founder of Neurona Therapeutics, to discuss an important milestone for the clinical-stage company. Neurona recently received the FDA’s Regenerative Medicine Advanced Therapy (RMAT) designation for … Continue reading A Conversation with CEO Cory Nicholas on Neurona Therapeutics’ Recent RMAT Designation